Categories: EHRNewsNutrition

NextEvo Naturals Releases New CBD Cream With Highest CBD Concentration on the Market

CONSHOHOCKEN, PA / ACCESSWIRE / April 2, 2024 / NextEvo Naturals (“NextEvo™” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, today announced the launch of a new maximum strength version of their popular CBD topical cream.

NextEvo Naturals Maximum Strength Revive + Restore Cream

Maximum Strength Revive + Restore CBD Cream is a fast-absorbing recovery cream that features the highest CBD concentration available on the market, at 5%. It is designed to soothe localized aches and pains with a gentle cooling effect that deeply penetrates for focused relief after a workout or any time of day.

This non-greasy formula also incorporates shea butter to soften the skin along with Vitamin E which acts as an antioxidant to protect the skin from free radicals. Furthermore, all of NextEvo Naturals’ CBD products are developed to the highest standards and thoroughly tested before they leave the manufacturing facility.

To purchase NextEvo’s Maximum Strength Revive + Restore CBD Cream, please visit https://nextevo.com/products/maximum-strength-cbd-lotion-cream.

About NextEvo Naturals

NextEvo Naturals is a premium supplement brand that has found a new way to revolutionize the delivery of cannabidiol (CBD) and other nutritional compounds by creating formulations that increase the compound’s potential benefits and consumer value. Led by medical professionals and former scientists from large reputable companies such as Johnson & Johnson, GlaxoSmithKline, and Schiff Nutrition, NextEvo Naturals aims to bridge the gap between the current low-quality CBD offerings on the market and the future of CBD supplements with proprietary technology and evidence-based data.

Stay up-to-date with NextEvo at https://nextevo.com as well as on Instagram, Twitter, and Facebook.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

NextEvo Naturals does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Contact Information

Katie Hanna
Content Manager
khanna@nextevo.com
561-685-9613

Lindsey VanderMaas Sobrinski
Director of Ecommerce and Marketing
lsobrinski@nextevo.com
484-336-7013

SOURCE: NextEvo Naturals

View the original press release on newswire.com.

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

23 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

23 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

23 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

23 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

23 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

23 hours ago